Amazon could be selling prescription drugs through recently acquired internet pharmacy PillPack sooner rather than later, according to experts who cite previous Amazon deals as examples. For instance, customers were able to take advantage of Amazon promotions at Whole Foods the day its acquisition of the grocery chain closed. (CNBC).

The Trump administration has named Uttam Dhillon as head of the Drug Enforcement Administration. Dhillon most recently served as deputy White House counsel. He is replacing Robert Patterson, who was named acting head of the DEA last October. (Reuters)

Purdue Pharma has stopped marketing its painkillers in Canada, more than four months after it did so in the U.S. The decision came after the Canadian government called on the company to suspend all opioid promotions. (Globe & Mail)

Insurers are trying a new tactic that is moving patients away from expensive drugs: effectively forcing drugmakers to pay more to help patients with copays. Drugmakers are trying tougher negotiating strategies in one response. (Reuters)

Biotech companies Stealth BioTherapeutics and AOBiome are planning to apply to file for IPOs in Hong Kong. The city’s stock exchange changed its regulations in April to attract more pharma companies. Neither Stealth BioTherapeutics nor AOBiome has operations in China. (Endpoints)